Scientists have found a way to 'intercept' pancreatic cancer. By inhibiting the cancer gene FGFR2, they were able to slow tumor formation. By targeting the FGFR2 and EGFR proteins, they were able to ...
By Hannah Furness The King has shared advice with fellow cancer patients by telling them: "What's that Winston Churchill saying? Keep buggering on." The monarch asked people who are living with ...
The company's first-generation product, LODER™, has shown promising results in a Phase 2 clinical trial for non-resectable pancreatic cancer. Silexion is also advancing its next-generation siRNA ...
COLD SPRING HARBOR, N.Y., April 2, 2025 /PRNewswire/ -- Pancreatic cancer is projected to become the second-deadliest cancer by 2030. By the time it's diagnosed, it's often difficult to treat.